NM_000629.3:c.502G>C
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000629.3(IFNAR1):c.502G>C(p.Val168Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.151 in 1,610,902 control chromosomes in the GnomAD database, including 21,248 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. V168V) has been classified as Benign.
Frequency
Consequence
NM_000629.3 missense
Scores
Clinical Significance
Conservation
Publications
- immunodeficiency 106, susceptibility to viral infectionsInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.163 AC: 24799AN: 152018Hom.: 2322 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.185 AC: 46302AN: 250954 AF XY: 0.186 show subpopulations
GnomAD4 exome AF: 0.150 AC: 218622AN: 1458768Hom.: 18918 Cov.: 30 AF XY: 0.153 AC XY: 111246AN XY: 725878 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.163 AC: 24812AN: 152134Hom.: 2330 Cov.: 33 AF XY: 0.165 AC XY: 12282AN XY: 74386 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
- -
- -
not specified Benign:1
This variant is classified as Benign based on local population frequency. This variant was detected in 40% of patients studied by a panel of primary immunodeficiencies. Number of patients: 38. Only high quality variants are reported. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at